Search research articles
Contact Us
Filters
Showing results (11-20 of 382) with videos related to
Page
of 39
Sort By:
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
January 31, 2013
Antihypertensive drugs and coronary artery disease : evidence from controlled trials
Paolo Verdecchia, Fabio Angeli
Giornale Italiano Di Cardiologia (2006)
|
December 22, 2012
[Waiting for the new oral anticoagulants: questions and answers about dabigatran]
Paolo Verdecchia, Giancarlo Agnelli
International Journal of Cardiology. Hypertension
|
April 5, 2021
Chronological age and vascular age staring at each other on the ring of cardiovascular prevention
Giacomo Pucci, Paolo Verdecchia
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
November 24, 2004
Reversal of left ventricular hypertrophy: what have recent trials taught us?
Paolo Verdecchia, Fabio Angeli
Giornale Italiano Di Cardiologia (2006)
|
September 9, 2008
[Obesity and hypertension]
Paolo Verdecchia, Bruno Trimarco
Clinical Therapeutics
|
June 11, 2004
Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or both
Paolo Verdecchia, Fabio Angeli
Circulation Research
|
March 14, 2015
Clinical value of ambulatory blood pressure: evidence and limits
Giuseppe Mancia, Paolo Verdecchia
Giornale Italiano Di Cardiologia (2006)
|
April 8, 2009
[The ONTARGET trial]
Paolo Verdecchia, Pierfranco Terrosu
Blood Pressure
|
December 8, 2004
Hypertension and microalbuminuria: the new detrimental duo
Paolo Verdecchia, Gian Paolo Reboldi
Giornale Italiano Di Cardiologia (2006)
|
October 25, 2024
[European guidelines for the management of hypertension: what's new?]
Paolo Verdecchia, Pasquale Perrone Filardi
Page
of 39
Search research articles
Search
Showing results (11-20 of 382) with videos related to
Sort By:
Page
of 39
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
January 31, 2013
Antihypertensive drugs and coronary artery disease : evidence from controlled trials
Paolo Verdecchia, Fabio Angeli
Giornale Italiano Di Cardiologia (2006)
|
December 22, 2012
[Waiting for the new oral anticoagulants: questions and answers about dabigatran]
Paolo Verdecchia, Giancarlo Agnelli
International Journal of Cardiology. Hypertension
|
April 5, 2021
Chronological age and vascular age staring at each other on the ring of cardiovascular prevention
Giacomo Pucci, Paolo Verdecchia
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
November 24, 2004
Reversal of left ventricular hypertrophy: what have recent trials taught us?
Paolo Verdecchia, Fabio Angeli
Giornale Italiano Di Cardiologia (2006)
|
September 9, 2008
[Obesity and hypertension]
Paolo Verdecchia, Bruno Trimarco
Clinical Therapeutics
|
June 11, 2004
Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or both
Paolo Verdecchia, Fabio Angeli
Circulation Research
|
March 14, 2015
Clinical value of ambulatory blood pressure: evidence and limits
Giuseppe Mancia, Paolo Verdecchia
Giornale Italiano Di Cardiologia (2006)
|
April 8, 2009
[The ONTARGET trial]
Paolo Verdecchia, Pierfranco Terrosu
Blood Pressure
|
December 8, 2004
Hypertension and microalbuminuria: the new detrimental duo
Paolo Verdecchia, Gian Paolo Reboldi
Giornale Italiano Di Cardiologia (2006)
|
October 25, 2024
[European guidelines for the management of hypertension: what's new?]
Paolo Verdecchia, Pasquale Perrone Filardi
Page
of 39